Skip to main content

UMD bioengineers develop new technologies to drive next-generation therapies for MS

By June 19, 2017News
umd-maryland-logo

umd-maryland-logo

Researchers in the University of Maryland (UMD) Fischell Department of Bioengineering (BIOE) Jewell Laboratory are using quantum dots – tiny semiconductor particles commonly used in nanotechnology – to decipher the features needed to design specific and effective therapies for multiple sclerosis (MS) and other autoimmune diseases. Their findings were published this week as the cover story of Advanced Functional Materials.

{iframe}https://eurekalert.org/pub_releases/2017-06/uom-ubd061317.php{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.